Advanced Functional Biomarker Testing

Comprehensive blood and functional lab analysis that goes significantly beyond standard panels. Dr. Dinetz orders and personally interprets testing across metabolic health, cardiovascular risk, thyroid function, micronutrient status, inflammatory markers, toxin and mold screening, gut health (including SIBO), and genomic evaluations. The goal is identifying upstream dysfunctions — patterns invisible on conventional labs — before they manifest as diagnosable conditions. Results are reviewed in the context of your full clinical picture, not compared against population averages alone.

Advanced Functional Biomarker Testing at Timeless Health MD represents one of the most clinically rigorous diagnostic offerings available in Miami's functional medicine landscape. Dr. Elliot Dinetz, a voluntary assistant professor at the University of Miami Miller School of Medicine and faculty member of the Age Management Medical Group (AMMG), applies training in metabolic and functional medicine to design and interpret bespoke lab panels that reflect individual physiology rather than population medians. The testing portfolio extends across multiple domains. Cardiovascular risk assessment goes beyond standard lipid panels to include advanced markers such as apolipoprotein fractions, oxidized LDL, homocysteine, and inflammatory indicators like high-sensitivity CRP. Thyroid evaluation includes TSH alongside free T3 and free T4 — a distinction that matters clinically, as many patients with suboptimal thyroid function are told their TSH is 'normal' when the active hormone picture tells a different story. Micronutrient and metabolic panels assess vitamins, minerals, amino acids, and organic acids at the cellular level, capturing functional deficiencies that serum-only testing can miss. Toxin and mold screening evaluates environmental exposures that may be quietly suppressing immune function or contributing to fatigue and neurological symptoms. Gut health testing, including markers associated with small intestinal bacterial overgrowth (SIBO), assesses the microbiome's contribution to systemic inflammation, mood, and metabolic regulation. Genomic evaluations — available through the Signature and higher-tier programs — map hereditary risk factors and pharmacogenomic sensitivities to guide long-term intervention priorities. All results are reviewed by Dr. Dinetz during a dedicated interpretation session where findings are contextualized and translated into an actionable protocol. The practice is self-pay and does not accept health insurance. HSA cards are accepted. Testing is available to patients attending in-office, via telemedicine, or through house call arrangements.